Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-31 @ 8:18 PM
Study NCT ID:
NCT00446095
Status:
COMPLETED
Last Update Posted:
2016-09-19
First Post:
2007-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
Sponsor:
Rigel Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4300C00023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None